Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Business Machines Corp (IBM) vs Illumina, Inc. (ILMN) Price & Performance

International Business Machines CorpTrade
Illumina, Inc.Trade

Price performance (Past 24H)

Key statistics

International Business Machines Corp vs Illumina, Inc. — how do they compare? International Business Machines Corp trades at $226 (market cap $213.50B), while Illumina, Inc. trades at $265.01 (market cap $39.95B). The key difference: International Business Machines Corp is far larger — about 5.3× Illumina, Inc.'s market cap, and International Business Machines Corp pays a 2.98% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 88 Days and Illumina, Inc. for 83 Days on average.

IBMILMN
Market Cap
$213.50B$39.95B
Volume
8,908,6873,169,503
Sector
TechnologyHealth
52-Week High
$329.23$293.69
52-Week Low
$205.77$91.00
Typical Hold Time
88 Days83 Days
Enterprise Value
$270.64B$41.31B
Dividend Yield
2.98%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

International Business Machines Corp

IBM trades at $220.51, down 0.35% with a bearish technical signal. The company reported strong Q1 2026 earnings beat but missed Q2 expectations. Revenue growth accelerated to $67.54B in 2025 with improved net margin of 15.52%. Recent news highlights IBM's AI platform expansion with self-hosted deployment options, while analyst consensus remains positive with a $256.69 price target representing 16% upside potential.

IBM presents a mixed investment case with solid fundamentals offset by technical weakness. The company's pivot to hybrid cloud and AI consulting shows promise with $5.5B in generative AI bookings, but faces execution risks amid cyclical mainframe weakness. Current valuation at 20.13 P/E appears reasonable given the 34.62% ROE, though near-term price pressure may persist until Q3 earnings clarity emerges.

Illumina, Inc.

Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.

The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBM
54% Buy46% Sell
Avg holding period · 88 Days
ILMN
96% Buy4% Sell
Avg holding period · 83 Days

Top news

Latest headlines on both assets

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.

Read more on IBM →

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN →